John Osborn
InvestorVenture Partner at Bioventures Investors
Pennsylvania
Writes $10M β $25M checks Β· typically $17.5M
About
John Osborn is a senior advisor at Hogan Lovells who brings experience as a Fortune 1000 company executive and general counsel in the life sciences industry, with expertise spanning M&A, corporate governance, intellectual property, and regulatory matters. He served at the U.S. Department of State from 1989 to 1992 under Secretary James A. Baker III and was confirmed by the Senate in 2008 as a member of the U.S. Advisory Commission on Public Diplomacy. Osborn holds academic affiliations including an affiliate professorship at the University of Washington School of Law and is a member of the Council on Foreign Relations and the American Law Institute.
Experience
- Hogan Lovells CadwaladerSenior Advisorcurrent2013 β presentWashington, DC
- BioVentures InvestorsVenture Partnercurrent2018 β presentGreater Boston Area
- University of Washington School of LawAffiliate Professorcurrent2012 β presentSeattle, Washington, United States
- University of Michigan - Stephen M. Ross School of BusinessGuest Lecturercurrent1997 β presentAnn Arbor, Michigan, United States
- UCLA Fielding School of Public HealthVisiting Scholar2018 β 2021Los Angeles, California, United States
- Egalet CorporationMember Board of Directors2015 β 2019Greater Philadelphia
- Warburg Pincus LLCExecutive-in-Residence and Industry Advisor2013 β 2016New York, New York, United States
- Onyx Pharmaceuticals, Inc., an Amgen subsidiarySenior Vice President, Global Corporate Affairs2012 β 2013San Francisco Bay Area
- DendreonExecutive Vice President, General Counsel & Secretary2011 β 2012Seattle, Washington, United States
- U.S. Advisory Commission on Public DiplomacyCommissioner2008 β 2011Washington, District of Columbia, United States
- McKessonExecutive Vice President & General Counsel, US Oncology Network2010 β 2011Greater Houston Area
- University of OxfordVisiting Fellow in Socio-Legal Studies2008Oxford, England, United Kingdom
- McKinsey & CompanyAdvisor2007 β 2008
- CephalonExecutive Vice President, General Counsel & Secretary1997 β 2008Greater Philadelphia Area
- Princeton UniversityVisiting Fellow and Research Collaborator in Politics2002 β 2007Princeton, New Jersey, United States
- Eisenhower FellowshipsFellow1998Belfast, Northern Ireland, United Kingdom
- MerckVice President & Associate General Counsel, DuPont Merck Pharmaceutical Company1992 β 1997Wilmington, Delaware, United States
- U.S. Department of StateSpecial Assistant to the Legal Adviser1989 β 1992Washington, District of Columbia, United States
- The Wilson CenterVisiting Scholar1991Washington, DC
- Dechert LLPAssociate1988 β 1989Philadelphia, Pennsylvania, United States
Education
- University of Virginia School of LawJD, Law1980 β 1983
- Princeton UniversityPostgraduate, Public and International Affairs1997 β 1999
- Johns Hopkins School of Advanced International Studies (SAIS)MIPP, European and Russian Studies1990 β 1992
- University of IowaBA, Economics and History1976 β 1979
- William & MaryUndergraduate, Arts and Sciences1975 β 1976
Skills & more
+12 more
Risk AssessmentLicensingPoliticsCrisis ManagementLegislationIntellectual PropertyReputationIssues ManagementMedia RelationsInternational TransactionsJoint VenturesGovernment Affairs- Member of the Bar, Commonwealth of Massachusetts, District of Columbia, Supreme Court of the United States
From John's professional profile.
Colleagues at Bioventures Investors
Frequently asked questions
- Where does John Osborn work?
- John Osborn is Venture Partner at Bioventures Investors.
- What check size does John Osborn write?
- John Osborn typically writes checks of $10M β $25M.
Same school
Also attended University of Virginia School of Law30
+ 24 more
Also attended Princeton University551
+ 545 more
Also attended Johns Hopkins School of Advanced International Studies (SAIS)38
+ 32 more
Also attended University of Iowa45
+ 39 more
Shared employers
Also worked at Warburg Pincus LLC72
+ 66 more
Also worked at Dendreon4
Also worked at McKinsey & Company1,453
+ 1,447 more
Also worked at Merck103
+ 97 more





























.jpg)

.png)















%20(1).png)
















